Built from the ground up, the ForagR Medicines RNA-centric, in-cell framework harnesses chemical genomics to stop diseases at their source
The ForagR platform solves the challenges of selectivity, progressability, and function that have bedeviled small-molecule RNA-targeted medicines.
Screening, hit-to-lead, and lead optimization are performed in cells to derisk targets, identify assets, and achieve functional modulation efficiently.
Company Details
- Employees
- 4
- Founded
- 2024
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.foragRmed.com/
- Keywords
- Durham.
Foragr Medicines Questions
Foragr Medicines's website is https://www.foragRmed.com/
Foragr Medicines's LinkedIn profile is https://www.linkedin.com/company/foragrmed
Foragr Medicines has
4 employees.
View email and phone details for 4
employees at Foragr Medicines.
Foragr Medicines's industry is
Biotechnology Research
Foragr Medicines's top competitors are
Piximune Therapeutics,
Pinetree Therapeutics Inc,
Enfuego Therapeutics,
Forge Biologics,
Cape Fear Biocapital,
Ribometrix Inc.,
North Carolina Biotechnology Center (Ncbiotech),
Ummino,
A-Form Solutions Inc.,
Exavir Therapeutics.
Foragr Medicines's categories are Biotechnology Research
Foragr Medicines's founding year is 2024
